$ZVRA
ZEVRA THERAPEUTICS, INC.

2017 Q1 Form 10-Q Financial Statement

#000143774917009824 Filed on May 22, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1 2015 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.270M $3.740M $2.570M
YoY Change -12.57% 281.63% 62.66%
% of Gross Profit
Research & Development $4.114M $3.234M $4.716M
YoY Change 27.21% 52.62% -20.22%
% of Gross Profit
Depreciation & Amortization $80.00K $26.00K $20.00K
YoY Change 207.69% 30.0% 100.0%
% of Gross Profit
Operating Expenses $7.380M $6.970M $7.282M
YoY Change 5.88% 125.13% -2.75%
Operating Profit -$7.380M -$6.970M -$7.282M
YoY Change 5.88% 125.13% -2.75%
Interest Expense $1.441M $1.150M $698.0K
YoY Change 25.3% 81.96% 10.62%
% of Operating Profit
Other Income/Expense, Net -$8.946M $4.048M -$1.922M
YoY Change -321.0% -241.0% -55.57%
Pretax Income -$16.33M -$2.922M -$9.204M
YoY Change 458.73% -51.03% -22.09%
Income Tax -$4.000K $12.00K -$1.000K
% Of Pretax Income
Net Earnings -$16.32M -$2.934M -$9.203M
YoY Change 456.31% -50.89% -22.28%
Net Earnings / Revenue
Basic Earnings Per Share -$1.11 -$0.20 -$0.64
Diluted Earnings Per Share -$1.11 -$0.20 -$0.64
COMMON SHARES
Basic Shares Outstanding 14.50M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.10M $111.0M $51.30M
YoY Change -44.95% 977.67% 398.06%
Cash & Equivalents $12.88M $77.33M $32.32M
Short-Term Investments $48.20M $33.70M $19.00M
Other Short-Term Assets $1.900M $400.0K $2.800M
YoY Change 375.0% 300.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables $0.00 $2.375M
Total Short-Term Assets $63.02M $111.4M $54.08M
YoY Change -43.42% 981.43% 426.15%
LONG-TERM ASSETS
Property, Plant & Equipment $2.201M $400.0K $403.0K
YoY Change 450.25% 0.0% 14.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.20M
YoY Change
Other Assets $260.0K $100.0K $109.0K
YoY Change 160.0% -97.06% -93.25%
Total Long-Term Assets $12.62M $513.0K $512.0K
YoY Change 2360.62% -86.5% -85.1%
TOTAL ASSETS
Total Short-Term Assets $63.02M $111.4M $54.08M
Total Long-Term Assets $12.62M $513.0K $512.0K
Total Assets $75.64M $111.9M $54.59M
YoY Change -32.4% 693.62% 298.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.600M $4.200M $1.252M
YoY Change 9.52% 5.0% -20.86%
Accrued Expenses $700.0K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $1.700M $3.400M
YoY Change -88.24% 1600.0%
Total Short-Term Liabilities $4.808M $5.845M $8.342M
YoY Change -17.74% 46.13% 111.99%
LONG-TERM LIABILITIES
Long-Term Debt $91.60M $90.10M $18.50M
YoY Change 1.66% 387.03% 2.21%
Other Long-Term Liabilities $1.368M $11.00K
YoY Change 12336.36% -99.94%
Total Long-Term Liabilities $1.368M $11.00K $0.00
YoY Change 12336.36% -99.97% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.808M $5.845M $8.342M
Total Long-Term Liabilities $1.368M $11.00K $0.00
Total Liabilities $109.6M $5.856M $64.71M
YoY Change 1771.07% -85.47% 70.22%
SHAREHOLDERS EQUITY
Retained Earnings -$137.7M -$107.8M -$104.8M
YoY Change 27.75% 108.98%
Common Stock $103.7M $96.28M $94.70M
YoY Change 7.75% 4813700.0% 5625.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$33.93M -$11.48M -$10.12M
YoY Change
Total Liabilities & Shareholders Equity $75.64M $111.9M $54.59M
YoY Change -32.43% 693.89% 298.06%

Cashflow Statement

Concept 2017 Q1 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income -$16.32M -$2.934M -$9.203M
YoY Change 456.31% -50.89% -22.28%
Depreciation, Depletion And Amortization $80.00K $26.00K $20.00K
YoY Change 207.69% 30.0% 100.0%
Cash From Operating Activities -$9.521M -$3.870M -$6.400M
YoY Change 146.02% -3.25% -8.05%
INVESTING ACTIVITIES
Capital Expenditures $99.00K $66.00K -$40.00K
YoY Change 50.0% 214.29% 33.33%
Acquisitions
YoY Change
Other Investing Activities $5.800M -$14.67M -$19.00M
YoY Change -139.54%
Cash From Investing Activities $5.702M -$14.73M -$19.04M
YoY Change -138.71% 73550.0% 63366.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -63.00K 63.61M -1.240M
YoY Change -100.1% 1478.41% -30.34%
NET CHANGE
Cash From Operating Activities -9.521M -3.870M -6.400M
Cash From Investing Activities 5.702M -14.73M -19.04M
Cash From Financing Activities -63.00K 63.61M -1.240M
Net Change In Cash -3.882M 45.01M -26.68M
YoY Change -108.62% 450000.0% 204.22%
FREE CASH FLOW
Cash From Operating Activities -$9.521M -$3.870M -$6.400M
Capital Expenditures $99.00K $66.00K -$40.00K
Free Cash Flow -$9.620M -$3.936M -$6.360M
YoY Change 144.41% -2.11% -8.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
CY2017Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2016Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
309000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10278000
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7216000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
260000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
360000
CY2017Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
41000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1368000
CY2016Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
583000
CY2017Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
26000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1153000
CY2017Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99000
CY2016Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
CY2017Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11670000
CY2016Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14666000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66000
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q1 kmph Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
7976
CY2017Q1 kmph Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
0
CY2017Q1 kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
230000
CY2016Q1 kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
CY2017Q1 kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4618000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
7216000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-10278000
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
37839000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11834000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27479000
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4740000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3266000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3736000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16326000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2922000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2867000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-679000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
68000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
11000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
206000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2372000
CY2017Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
101000
CY2016Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
102000
CY2017Q1 us-gaap Interest Expense
InterestExpense
1441000
CY2016Q1 us-gaap Interest Expense
InterestExpense
1150000
CY2017Q1 us-gaap Interest Paid
InterestPaid
2617000
CY2016Q1 us-gaap Interest Paid
InterestPaid
182000
CY2017Q1 us-gaap Liabilities
Liabilities
109570000
CY2016Q4 us-gaap Liabilities
Liabilities
103583000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75641000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84887000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4808000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6642000
CY2017Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
11834000
CY2016Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
4618000
CY2017Q1 us-gaap Long Term Investments
LongTermInvestments
10162000
CY2016Q4 us-gaap Long Term Investments
LongTermInvestments
8200000
CY2017Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
48243000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9521000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3865000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-16322000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7380000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6970000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
51003000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-63000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63612000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5702000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14732000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-2934000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8946000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4048000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
7380000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
6970000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
795000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
489000
CY2017Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
CY2016Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
82800000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17471000
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2017Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2016Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2201000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1970000
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
37000
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8000
CY2017Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2016Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18621000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4114000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3234000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2016 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
3
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137662000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121340000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1089000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1022000
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
13333
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-33929000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-18696000
CY2015Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
7.5
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14646982
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14495703
CY2017Q1 kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
CY2016Q1 kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
82000
CY2017Q1 kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
2000
CY2016Q1 kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
12000
CY2017Q1 kmph Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
CY2016Q1 kmph Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
82000
CY2016Q1 kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
445000
CY2017Q1 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
11834000
CY2016Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
4618000
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4584000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6444000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5003000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103732000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102643000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11703648
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11354118
CY2017Q1 us-gaap Assets
Assets
75641000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1089000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1022000
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1031000
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
968000
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2016Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
442000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
63018000
CY2016Q4 us-gaap Assets
Assets
84887000
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
162000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
157000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16762000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32318000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12880000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77333000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
74357000
CY2017Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
58405000
CY2016Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
59203000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14646982
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14646982
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14646982
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14646982
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3882000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
45015000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12699698
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12114618
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
1000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2017Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
91560000
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
91170000

Files In Submission

Name View Source Status
0001437749-17-009824-index-headers.html Edgar Link pending
0001437749-17-009824-index.html Edgar Link pending
0001437749-17-009824.txt Edgar Link pending
0001437749-17-009824-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20170331.xml Edgar Link completed
kmph-20170331.xsd Edgar Link pending
kmph-20170331_cal.xml Edgar Link unprocessable
kmph-20170331_def.xml Edgar Link unprocessable
kmph-20170331_lab.xml Edgar Link unprocessable
kmph-20170331_pre.xml Edgar Link unprocessable
kmph20170331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending